The Perrigo Company is voluntarily recalling two batches of its children’s Guaifenesin grape liquid (100mg/5 mL) and three batches of its children’s Guaifenesin DM cherry liquid (100mg guaifenesin and 5mg dextromethorphan HBr/ 5 ml) after a dosing cup with the wrong markings was included with the 4 oz. bottles. The medications are sold at nine major stores under different brand names across the country. (See below for a full list)
The U.S. Food and Drug Administration (FDA) is aware of the recall. A company statement says that using these recalled products “according to labeled instructions with an affected dosing cup is unlikely to result in serious side effects”, and it says that there have been no reports of anyone becoming sick.
“There have been no reports of adverse events to Perrigo as a result of the incorrect dosage markings,” Perrigo’s Chairman and CEO Joseph C. Papa said in a statement. “Perrigo is taking this action to maintain the highest possible product quality standards for our retail customers and consumers. We are taking this action because it is the right thing to do.”
Recalled lots, along with their corresponding branded labels, are listed below:
GUAIFENESIN GRAPE LIQ 4 OZ
GUAIFENESIN DM CHRY LIQ 4 OZ
|Topcare||5LK0528, 5LK0630, 5LK0779||03/2017|